Source link : https://www.newshealth.biz/health-news/fda-oks-new-tool-to-aid-dx-of-degenerative-brain-diseases/
The US Food and Drug Administration (FDA) has cleared NM-101 (Terran Biosciences), a cloud-based software platform to analyze neuromelanin-sensitive MRI scans, which could aid in the diagnosis of neurodegenerative diseases. Research has suggested that neuromelanin is a potential biomarker for neurologic disorders such as Parkinson’s disease (PD). A recent meta-analysis of 12 neuromelanin MRI studies […]
Author : News Health
Publish date : 2024-01-09 22:30:35
Copyright for syndicated content belongs to the linked Source.